Teva Pharmaceutical Industries research and development expenses for the twelve months ending June 30, 2024 were $990M, a 15.25% increase year-over-year.
Teva Pharmaceutical Industries annual research and development expenses for 2023 were $0.953B, a 13.72% increase from 2022.
Teva Pharmaceutical Industries annual research and development expenses for 2022 were $0.838B, a 13.34% decline from 2021.
Teva Pharmaceutical Industries annual research and development expenses for 2021 were $0.967B, a 3.01% decline from 2020.
Teva Pharmaceutical Industries Research and Development Expenses 2010-2024 | TEVA